The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index
Open accessAbstract
OBJECTIVE: The purpose of this study was to characterize the relationships among plasma adiponectin, essential hypertension, left ventricular diastolic function and left ventricular hypertrophy. METHODS AND RESULTS: Plasma adiponectin concentration was assessed by radioimmunoassay, and body mass index (BMI) was measured in 275 patients (138 women and 137 men). Various echocardiographic parameters such as deceleration time (DT) and isovolumetric relaxation time (IVRT) were measured by using echocardiograms. The authors calculated left ventricular mass index (LVMI) and E/A ratio. Pulse wave velocity (PWV) was calculated by dividing the distance between the left subclavian artery ostium and the tip of the femoral sheath with the time interval between two pulse waves. The plasma adiponectin concentration of the hypertensive group was significantly lower than that of the non-hypertensive group (9.9 +/- 9.8 microg/ml vs. 12.9 +/- 9.5 microg/ml, p = 0.019). PWV in the hypertensive group was 12.0 +/- 3.9 m/s compared with 9.3 +/- 2.8 m/s in the normotensive group (p < 0.001). LVMI in the hypertensive group was 135.1 +/- 35.4 g/m2 compared with 100.5 +/- 18.7 g/m2 in the normotensive group (p < 0.001). E/A ratio (0.8 +/- 0.3 vs. 1.1 +/- 0.4, p = 0.041) was lower in the hypertensive group. DT (200.0 +/- 61.2 ms vs. 177.3 +/- 40.8 ms, p = 0.048) and IVRT (106.9 +/- 25.4 vs. 91.3 +/- 27.6 ms, p = 0.243) were higher in the hypertensive group. Plasma adiponectin showed an inverse correlation with LVMI (r = -0.525; p < 0.001) and PWV (r = -0.557; p < 0.001), IVRT (r = -0.485; p = 0.008), and showed a positive correlation with E/A ratio (r = 0.359; p < 0.001). Multiple regression analyses showed that PWV and plasma adiponectin were able to explain the 73.3% of LVMI variability (r = 0.856; p < 0.001). CONCLUSION: The results suggest that a decrease in plasma adiponectin concentration is associated with the progression of left ventricular hypertrophy with diastolic dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“First, an important pathophysiological contribution was suggested by the recent explosion in the number of clinical studies that have established correlations between plasma adiponectin levels and various aspects and severity of heart failure (107, 113, 143, 166, 172, 183, 198, 209, 251, 275, 282, 286, 303, 312, 366).”
From Cardiac remodeling in obesity (2008) · cites this paper as [143]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133
Novel Modulator for Endothelial Adhesion Molecules
Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., Hotta, K., Nishida, M., Takahashi, M., Nakamura, T., et al. (1999) · Circulation · doi:10.1161/01.cir.100.25.2473 · Cited by 2,158
Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., & Matsubara, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0587 · Cited by 2,081
Ouchi, N., Kihara, S., Arita, Y., Okamoto, Y., Maeda, K., Kuriyama, H., Hotta, K., Nishida, M., Takahashi, M., Muraguchi, M., et al. (2000) · Circulation · doi:10.1161/01.cir.102.11.1296 · Cited by 1,730
Association of Hypoadiponectinemia With Coronary Artery Disease in Men
Kumada, M., Kihara, S., Sumitsuji, S., Kawamoto, T., Matsumoto, S., Ouchi, N., Arita, Y., Okamoto, Y., Shimomura, I., Hiraoka, H., et al. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000048856.22331.50 · Cited by 1,419
Ouchi, N., Kihara, S., Arita, Y., Nishida, M., Matsuyama, A., Okamoto, Y., Ishigami, M., Kuriyama, H., Kishida, K., Nishizawa, H., et al. (2001) · Circulation · doi:10.1161/01.cir.103.8.1057 · Cited by 1,281
Disruption of Adiponectin Causes Insulin Resistance and Neointimal Formation
Kubota, N., Terauchi, Y., Yamauchi, T., Kubota, T., Moroi, M., Matsui, J., Eto, K., Yamashita, T., Kamon, J., Satoh, H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200251200 · Cited by 1,213
Disruption of adiponectin causes insulin resistance and neointimal formation
Froguel, P. (2002) · HAL · Cited by 1,126
The role of the novel adipocyte-derived hormone adiponectin in human disease
Díez, J. J., & Iglesias, P. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480293 · Cited by 1,119
Research works printed but not linked: 2
- Garcia MJ, 1998, New Doppler echocar-diographic applications for the study of diastolic function. J Am Coll Cardiol, 32, 865
- Mallamaci F, 2002, J Nephrol, 15, 507
Cited by
Sorted by citations
Adipokines in inflammation and metabolic disease
Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011) · Nature Reviews Immunology · doi:10.1038/nri2921 · Cited by 4,625
Abel, E. D., Litwin, S. E., & Sweeney, G. (2008) · Physiological Reviews · doi:10.1152/physrev.00017.2007 · Cited by 736
Fuster, J. J., Ouchi, N., Gokce, N., & Walsh, K. X. (2016) · Circulation Research · doi:10.1161/circresaha.115.306885 · Cited by 691
Adiponectin regulation and function
Fang, H., & Judd, R. L. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170046 · Cited by 631
Adipokines: A link between obesity and cardiovascular disease
Nakamura, K., Fuster, J. J., & Walsh, K. X. (2013) · Journal of Cardiology · doi:10.1016/j.jjcc.2013.11.006 · Cited by 597
Adiponectin: a key adipocytokine in metabolic syndrome
Okamoto, Y., Kihara, S., Funahashi, T., Matsuzawa, Y., & Libby, P. (2006) · Clinical Science · doi:10.1042/cs20050182 · Cited by 445
The role of leptin/adiponectin ratio in metabolic syndrome and diabetes
López-Jaramillo, P., Gómez-Arbeláez, D., López-López, J., López-López, C., Martínez-Ortega, J., Gómez-Rodríguez, A., & Triana-Cubillos, S. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2013-0053 · Cited by 405
T-cadherin is critical for adiponectin-mediated cardioprotection in mice
Denzel, M. S., Scimia, M. C., Zumstein, P., Walsh, K. X., Ruiz‐Lozano, P., & Ranscht, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43464 · Cited by 345
Bariatric surgery and cardiovascular outcomes: a systematic review
Vest, A. R., Heneghan, H. M., Agarwal, S., Schauer, P. R., & Young, J. B. (2012) · Heart · doi:10.1136/heartjnl-2012-301778 · Cited by 336
Adiponectin actions in the cardiovascular system
Hopkins, T. A., Ouchi, N., Shibata, R., & Walsh, K. X. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.10.009 · Cited by 331
Obesity in Dogs and Cats: A Metabolic and Endocrine Disorder
Zoran, D. L. (2010) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2009.10.009 · Cited by 312
Adiponectin and Cardiovascular Disease
Shibata, R., Ouchi, N., & Murohara, T. (2009) · Circulation Journal · doi:10.1253/circj.cj-09-0057 · Cited by 214
Poornima, I. G., Brown, S. B., Bhashyam, S., Parikh, P., Bölükoglu, H., & Shannon, R. P. (2008) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.766402 · Cited by 183
Adipokines, Myokines and Cardiovascular Disease
Walsh, K. X. (2008) · Circulation Journal · doi:10.1253/circj.cj-08-0961 · Cited by 178
Adiponectin Levels and the Risk of Hypertension
Kim, D. H., Kim, C., Ding, E. L., Townsend, M. K., & Lipsitz, L. A. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01453 · Cited by 165
Adipokines: a review of biological and analytical principles and an update in dogs, cats, and horses
Radin, M. J., Sharkey, L. C., & Holycross, B. J. (2009) · Veterinary Clinical Pathology · doi:10.1111/j.1939-165x.2009.00133.x · Cited by 173
Fallo, F., Pozza, A. D., Sonino, N., Lupia, M., Tona, F., Federspil, G., Ermani, M., Catena, C., Soardo, G., Piazza, L. D., et al. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.12.007 · Cited by 114
Konishi, M., Haraguchi, G., Ohigashi, H., Ishihara, T., Saito, K., Nakano, Y., & Isobe, M. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq335 · Cited by 97
Metabolic Syndrome, Chronic Kidney, and Cardiovascular Diseases: Role of Adipokines
Tesauro, M., Canale, M. P., Rodia, G., Daniele, N. D., Lauro, D., Scuteri, A., & Cardillo, C. (2011) · Cardiology Research and Practice · doi:10.4061/2011/653182 · Cited by 92
Direct effects of adipokines on the heart: focus on adiponectin
Park, M. S., & Sweeney, G. (2012) · Heart Failure Reviews · doi:10.1007/s10741-012-9337-8 · Cited by 79
Adiponectin Levels Associated with the Development of Hypertension: A Prospective Study
Imatoh, T., Miyazaki, M., Momose, Y., Tanihara, S., & Hiroshi, U. N. E. (2008) · Hypertension Research · doi:10.1291/hypres.31.229 · Cited by 67
Cardiometabolic effects of adiponectin
Parker, J., & Walsh, K. X. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.09.001 · Cited by 64
Myocardial Tissue Remodeling in Adolescent Obesity
Shah, R. V., Abbasi, S. A., Neilan, T. G., Hulten, E. A., Coelho‐Filho, O. R., Hoppin, A. G., Levitsky, L. L., de Ferranti, S. D., Rhodes, E. T., Traum, A. Z., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000279 · Cited by 64
Cao, J. J., Singh, S. P., McClung, J. A., Joseph, G. U., Vanella, L., Barbagallo, I. A., Jiang, H., Falck, J. R., Arad, M., Shapiro, J. I., et al. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00093.2017 · Cited by 65
Adiponectin Level and Left Ventricular Hypertrophy in Japanese Men
Mitsuhashi, H., Yatsuya, H., Tamakoshi, K., Matsushita, K., Otsuka, R., Wada, K., Sugiura, K., Takefuji, S., Hotta, Y., Kondo, T., et al. (2007) · Hypertension · doi:10.1161/hypertensionaha.106.079509 · Cited by 64
Short-Chain Fatty Acids in Gut–Heart Axis: Their Role in the Pathology of Heart Failure
Iwashita, M., Nagatomo, Y., Kawai, A., Taruoka, A., Yumita, Y., Kagami, K., Yasuda, R., Toya, T., Ikegami, Y., Masaki, N., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12111805 · Cited by 68
Lewandowski, K. C., Szosland, K., O’Callaghan, C. J., Tan, B. K., Randeva, H. S., & Lewiñski, A. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.12.014 · Cited by 62
Brooks, N. L., Moore, K. S., Clark, R. D., Perfetti, M. T., Trent, C. M., & Combs, T. P. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00596.x · Cited by 59
Lubkowska, A., Radecka, A., Bryczkowska, I., Rotter, I., Laszczyńska, M., & Dudzińska, W. (2015) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph120911528 · Cited by 57
An update on the role of adipokines in arterial stiffness and hypertension
Sabbatini, A. R., Fontana, V., Laurent, S., & Moreno, H. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000444 · Cited by 55
Adiponectin and Left Ventricular Structure and Function in Healthy Adults
Kozàkovà, M., Muscelli, E., Flyvbjerg, A., Frystyk, J., Morizzo, C., Palombo, C., & Ferrannini, E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2580 · Cited by 53
The Role of Adiponectin in Cardiometabolic Diseases: Effects of Nutritional Interventions
López-Jaramillo, P. A. (2016) · Journal of Nutrition · doi:10.3945/jn.114.202432 · Cited by 49
Sharma, A., Mah, M., Ritchie, R. H., & Blasio, M. J. D. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108008 · Cited by 52
de Faria, A. P., Demacq, C., Figueiredo, V. N., Moraes, C. D. H., Santos, R. C., Sabbatini, A. R., Barbaro, N. R., Boer‐Martins, L., Fontana, V., & Moreno, H. (2013) · Hypertension Research · doi:10.1038/hr.2013.92 · Cited by 49
Zhang, N., Wei, W., Liao, H.-H., Yang, Z., Hu, C., Wang, S., Deng, W., & Tang, Q. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1696-8 · Cited by 48
Relationship Between Adiponectin and Ambulatory Blood Pressure in Obese Adolescents
Shatat, I. F., Freeman, K. D., Vuguin, P. M., DiMartino-Nardi, J., & Flynn, J. T. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31819ea776 · Cited by 46
The Pathophysiology of Cardiac Hypertrophy and Heart Failure
Stansfield, W. E., Ranek, M. J., Pendse, A. A., Schisler, J. C., Wang, S., Pulinilkunnil, T., & Willis, M. S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405206-2.00004-1 · Cited by 46
Adipokines: Novel Players in Resistant Hypertension
de Faria, A. P., Modolo, R., Fontana, V., & Moreno, H. (2014) · Journal of Clinical Hypertension · doi:10.1111/jch.12399 · Cited by 44
Association of Adiponectin With Left Ventricular Mass in Blacks
Bidulescu, A., Liu, J., Musani, S. K., Fox, E. R., Samdarshi, T. E., Sarpong, D. F., Vaccarino, V., Wilson, P. W. F., Arnett, D. K., Din‐Dzietham, R., et al. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.110.959742 · Cited by 41
Deregulation of adipokines related to target organ damage on resistant hypertension
Sabbatini, A. R., de Faria, A. P., Barbaro, N. R., Gordo, W. M., Modolo, R., Pinho, C., Fontana, V., & Moreno, H. (2013) · Journal of Human Hypertension · doi:10.1038/jhh.2013.118 · Cited by 41
Adiponectin Provides Cardiovascular Protection in Metabolic Syndrome
Okamoto, Y. (2011) · Cardiology Research and Practice · doi:10.4061/2011/313179 · Cited by 40
Left Ventricular Diastolic Dysfunction in Diabetic Patients
Tsujino, T., Kawasaki, D., & Masuyama, T. (2006) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200606040-00002 · Cited by 34
Impact of Adiponectin on Left Ventricular Mass Index in Non-complicated Obese Subjects
Ebinç, H., Ebinç, F. A., Özkurt, Z. N., Doğru, M., Tulmaç, M., Yılmaz, M., & Çağlayan, O. (2008) · Endocrine Journal · doi:10.1507/endocrj.k07e-098 · Cited by 34
Targeting adiponectin for cardioprotection
Ouchi, N., Shibata, R., & Walsh, K. X. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.4.573 · Cited by 33
Heart Failure With Preserved Ejection Fraction and Adipose Tissue: A Story of Two Tales
Oh, A., Okazaki, R. A., Sam, F., & Valero‐Muñoz, M. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00110 · Cited by 32
Prasatthong, P., Meephat, S., Rattanakanokchai, S., Khamseekaew, J., Bunbupha, S., Prachaney, P., Maneesai, P., & Pakdeechote, P. (2021) · Antioxidants · doi:10.3390/antiox10050769 · Cited by 33
Hong, S. J., Choi, S.-C., Ahn, C. M., Park, J. H., Kim, J. S., & Lim, D.-S. (2011) · Heart · doi:10.1136/hrt.2011.225193 · Cited by 31
Self-citationBlasi, E., Heyen, J. R. R., Hemkens, M. D., McHarg, A. D., ECELBARGER, C. A., & Tiwari, S. (2009) · PPAR Research · doi:10.1155/2009/237865 · Cited by 29
Chiara, T. D., Licata, A., Argano, C., Duro, G., Corrao, S., & Scaglione, R. (2013) · Blood Pressure · doi:10.3109/08037051.2013.823767 · Cited by 27
Unno, K., Shibata, R., Izawa, H., Hirashiki, A., Murase, Y., Yamada, T., Kobayashi, M., Noda, A., Nagata, K., Ouchi, N., et al. (2009) · Heart · doi:10.1136/hrt.2009.172320 · Cited by 26
Serum adiponectin complexes and cardiovascular risk in children with chronic kidney disease
Lo, M. M., Salisbury, S. R., Scherer, P. E., Furth, S. L., Warady, B. A., & Mitsnefes, M. M. (2011) · Pediatric Nephrology · doi:10.1007/s00467-011-1906-x · Cited by 23
Komaba, H., Igaki, N., Goto, S., Yokota, K., Takemoto, T., Hirosue, Y., & Goto, T. (2007) · Nephron Clinical Practice · doi:10.1159/000108651 · Cited by 24
Ebinç, F. A., Ebinç, H., Derici, Ü., Aral, A., Aybay, C., Taçoy, G. A., Koç, E., Mutluay, R., Reis, K. A., Erten, Y., et al. (2009) · Journal of Nephrology · doi:10.1093/joneph/22.2.216 · Cited by 22
Fukuta, H., Ohte, N., Wakami, K., Goto, T., Tani, T., & Kimura, G. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.06.005 · Cited by 21
Adiponectin in the Heart and Vascular System
Ding, M., Rzucidlo, E. M., Davey, J. C., Xie, Y., Liu, R., Jin, Y., Stavola, L. K., & Martin, K. A. (2012) · Vitamins and hormones · doi:10.1016/b978-0-12-398313-8.00011-7 · Cited by 21
Adiponectin and the cardiovascular system: from risk to disease
Tarquini, R., Lazzeri, C., Laffi, G., & Gensini, G. F. (2007) · Internal and Emergency Medicine · doi:10.1007/s11739-007-0027-9 · Cited by 21
Kolasa‐Trela, R., Miszalski−Jamka, T., Grudzień, G., Wypasek, E., & Kostkiewicz, M. (2011) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.1091 · Cited by 20
Sabouri, S., Ghayour‐Mobarhan, M., Moohebati, M., Hassani, M., Kasaian, J., Tatari, F., Kordi, F. M., Esmaeili, H. A., Tavallaie, S., Paydar, R., et al. (2011) · The Scientific World JOURNAL · doi:10.1100/tsw.2011.3 · Cited by 20
Gustafsson, S., Lind, L., Zethelius, B., Venge, P., Flyvbjerg, A., Söderberg, S., & Ingelsson, E. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-1006 · Cited by 21
Sawaguchi, T., Nakajima, T., Haruyama, A., Hasegawa, T., Shibasaki, I., Nakajima, T., Kaneda, H., Arikawa, T., Obi, S., Sakuma, M., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225008 · Cited by 20
Sawada, N., Daimon, M., Kawata, T., Nakao, T., Kimura, K., Nakanishi, K., Kurano, M., Hirokawa, M., Xu, B., Yamanaka, Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37137-x · Cited by 19
Baltrūnienė, V., Bironaitė, D., Kažukauskienė, I., Bogomolovas, J., Vitkus, D., Ručinskas, K., Žurauskas, E., Augulis, R., & Grabauskienė, V. (2017) · BioMed Research International · doi:10.1155/2017/3818292 · Cited by 20
Siddiqui, M. B., Patel, S. S., Arshad, T., Lee, E., Albhaisi, S. A. M., Driscoll, C. J., Wolver, S. E., Reichman, T., Bhati, C. S., & Siddiqui, M. S. (2019) · Transplantation · doi:10.1097/tp.0000000000002714 · Cited by 19
Metabolic Syndrome, Adiponectin, Sleep, and the Circadian System
Cornélissen, G. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.06.013 · Cited by 17
Lee, Y., Kim, B. K., Lim, Y., Kim, M. K., Choi, B. Y., & Shin, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070246 · Cited by 17
Pääkkö, T., Ukkola, O. H., Ikäheimo, M. J., & Kesäniemi, Y. A. (2010) · Annals of Medicine · doi:10.3109/07853890903449827 · Cited by 17
Angiotensin II Reduces Cardiac AdipoR1 Expression through AT1 Receptor/ROS/ERK1/2/c-Myc Pathway
Li, L., Zhang, Z., Lei, H., Wang, C., Wu, L., Wang, J., Fu, F.-Y., Zhu, W., & Wu, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0049915 · Cited by 16
Iacobellis, G., Petrone, A., Leonetti, F., & Buzzetti, R. (2006) · Obesity · doi:10.1038/oby.2006.48 · Cited by 15
Plasma Adiponectin Levels and Left Ventricular Remodeling in Hypertrophic Cardiomyopathy
Kitaoka, H., Kubo, T., Okawa, M., Yamasaki, N., Matsumura, Y., Nishinaga, M., & Doi, Y. (2010) · International Heart Journal · doi:10.1536/ihj.51.51 · Cited by 15
Fu, M., Zhou, J., Qian, J., Jin, X., Zhu, H., Zhong, C., Fu, M. L. X., Zou, Y., & Ge, J. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-106 · Cited by 15
Puchałowicz, K., Kłoda, K., Dziedziejko, V., Rać, M. E., Wojtarowicz, A., Chlubek, D., & Safranow, K. (2021) · Diagnostics · doi:10.3390/diagnostics11101774 · Cited by 15
Cardiac hypertrophy with obesity is augmented after pregnancy in C57BL/6 mice
Che, C., Dudick, K., & Shoemaker, R. (2019) · Biology of Sex Differences · doi:10.1186/s13293-019-0269-z · Cited by 14
Hypoadiponectinemia, cardiometabolic comorbidities and left ventricular hypertrophy
Chiara, T. D., Argano, C., Scaglione, A., Duro, G., Corrao, S., Scaglione, R., & Licata, G. (2014) · Internal and Emergency Medicine · doi:10.1007/s11739-014-1104-5 · Cited by 15
What can adiponectin say about left ventricular function?
Sam, F., & Walsh, K. X. (2009) · Heart · doi:10.1136/hrt.2009.178590 · Cited by 14
Liao, Y., Xuan, W., Zhao, J., Bin, J., Zhao, H., Asakura, M., Funahashi, T., Takashima, S., & Kitakaze, M. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.039 · Cited by 13
Akıncı, A., Karakurt, C., Gürbüz, S., Elkran, O., Nalbantoğlu, Ö., Koçak, G., Güldür, T., & Yoloğlu, S. (2012) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e328351674e · Cited by 13
Lipotoxicity as a therapeutic target in the type 2 diabetic heart
Luong, T. V. T., Yang, S., & Kim, J. (2025) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2025.02.010 · Cited by 12
Tsai, W., Lin, C., Chen, J., Huang, Y., Lee, C., Li, W., Weng, C.-M., & Chen, J.-H. (2008) · Blood Pressure · doi:10.1080/08037050802308895 · Cited by 12
Adiponectin, cardiovascular disease, chronic kidney disease: emerging data on complex interactions
Lo, M. M., & Mitsnefes, M. M. (2011) · Pediatric Nephrology · doi:10.1007/s00467-011-1804-2 · Cited by 12
Myocardial Mitochondrial and Contractile Function Are Preserved in Mice Lacking Adiponectin
Braun, M., Hettinger, N., Koentges, C., Pfeil, K., Cimolai, M. C., Hoffmann, M. M., Osterholt, M., Doenst, T., Bode, C., & Bugger, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119416 · Cited by 12
Top, C., Şahan, B., & Önde, M. E. (2007) · Journal of International Medical Research · doi:10.1177/147323000703500621 · Cited by 13
Inoué, T., Takemori, K., Mizuguchi, N., Kimura, M., Chikugo, T., Hagiyama, M., Yoneshige, A., Mori, T., Maenishi, O., Kometani, T., et al. (2017) · Experimental Physiology · doi:10.1113/ep086407 · Cited by 11
Wang, J., Zhang, J., Ding, X., Wang, Y., Li, Z. ⁄., Zhao, W., Jia, J., Zhou, J., & Ge, J. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3370 · Cited by 9
Adipokines and Their Receptors: Potential New Targets in Cardiovascular Diseases
Gonçalves, N., Falcão‐Pires, I., & Leite-Moreira, A. F. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.14.147 · Cited by 8
The importance of caveolin as a target in the prevention and treatment of diabetic cardiomyopathy
Xia, W., Li, X., Wu, Q., Xu, A., Zhang, L., & Xia, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.951381 · Cited by 8
Potential of Adiponectin as a Cardioprotective Agent
Shibata, R., Ouchi, N., Walsh, K. X., & Murohara, T. (2007) · Future Cardiology · doi:10.2217/14796678.3.6.647 · Cited by 8
Özkan, B., Açar, G., Alıcı, G., Alızade, E., Tabakçı, M. M., Şahin, M., Yazıcıoğlu, M. V., Özkök, A., Tanboğa, İ. H., Coşkun, C., et al. (2013) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2013.783053 · Cited by 7
Piestrzeniewicz, K., Maciejewski, M., & Goch, J. H. (2008) · Cited by 7
Plasma adiponectin concentration and left ventricular hypertrophy in kidney transplant patients
Adamczak, M., Błach, A., Kolonko, A., Szotowska, M., Chudek, J. T., Franek, E., & Więcek, A. (2010) · Clinical Transplantation · doi:10.1111/j.1399-0012.2010.01330.x · Cited by 6
Plasma adiponectin in hypertensive patients with and without metabolic syndrome
Brzeska, A., Sołtysiak, M., Ziemak, J., Miazgowski, T., & Widecka, K. (2018) · Arterial Hypertension · doi:10.5603/ah.a2017.0025 · Cited by 6
Fukuta, H., Goto, T., & Kamiya, T. (2024) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2024.101444 · Cited by 6
Interactions between CKD and MetS and the Development of CVD
Aihara, K., Mogi, M., Shibata, R., Bishop‐Bailey, D., & Ma, X. L. (2011) · Cardiology Research and Practice · doi:10.4061/2011/878065 · Cited by 5
Sîrbu, A. M., Stanca, I., Copăescu, C., Martin, S. C., Albu, A. I., Barbu, C. G., & Fica, S. V. (2013) · PubMed · doi:10.3275/8924 · Cited by 6
Czerwieńska, B., Lelek, M., Gojowy, D., Surma, S., Mizia‐Stec, K., Więcek, A., & Adamczak, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12062114 · Cited by 5
Dong, L., Shi, G., Xu, M., Yin, J., Liu, Y., Yang, J., & Xu, L. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14162 · Cited by 5
[The role of adiponectin in pathogenesis of metabolic syndrome and cardiovascular disease].
Kozłowska, A., & Kowalska, I. (2006) · PubMed · Cited by 5
Adiponectin and Cardiac Hypertrophy in Acromegaly
Gürbulak, S., Akın, F., Yerli̇kaya, E., Yaylalı, G. F., Topsakal, Ş., Tanriverdi, H. I., Akdağ, B., & Kaptanoğlu, B. (2016) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/35639 · Cited by 5
Alencar, A. K. N., Wang, H., de Oliveira, G. M. M., Sun, X., Zapata‐Sudo, G., & Groban, L. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20200855 · Cited by 6
Coronary Atherosclerosis : Adiponectin and Leptin as Predictors of Disease Severity
Mahgoub, S. S., Hammoudeh, A. J., Al-Shagahin, H., Soub, M. N. A., Masarweh, O., Abdo, M. A., Atoom, S. N. A., & Alzaraq, A. W. (2014) · Jordan Journal of Biological Sciences · doi:10.12816/0008235 · Cited by 3
Exercise modulates circulating adipokine levels in hypertrophic cardiomyopathy
Dimitrow, P. P., Undas, A., & Cheng, T. O. (2011) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.1097 · Cited by 4
Metadata
- Authors
- Hong, S. J., Park, C. G., Seo, H. S., Oh, D. J., & Ro, Y. M.
- Affiliations
- Korea University (KR)
- Corresponding author
- Park, Chang Gyu
- Venue
- Blood Pressure
- Publisher
- Informa UK Limited
- Published
- 2004-01
- Volume
- 13
- Issue
- 4
- Pages
- 236-242
- ISSN
- 0803-7051 (ISSN-L)
- 1651-1999
- OpenAlex
- W2016738173
- Cited by
- 121
- References
- 20
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 4 · 2020: 2 · 2019: 5 · 2018: 9 · 2017: 3 · 2016: 4 · 2015: 3 · 2014: 6 · 2013: 13 · 2012: 8
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood Pressure (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- adiponectin, essential hypertension, left ventricular diastolic function, left ventricular hypertrophy, left ventricular mass index, pulse wave velocity, arterial stiffness, diastolic relaxation, isovolumic relaxation time, deceleration time, E/A ratio, body mass index, adipokines, cardiovascular risk factors, echocardiography, pulse wave analysis
- MeSH terms
- Adult, Aged, Blood Pressure, Echocardiography, Female, Heart Ventricles, Humans, Hypertension, Male, Middle Aged, Case-Control Studies, Ventricular Function, Left, Intercellular Signaling Peptides and Proteins, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review